Mimetica is a drug discovery company that uses its patented peptide mimetics technology to produce new drugs based on the structure of natural hormones and peptides. The uniquely flexible chemistry technology allows accurate turn and helix mimetics to be made for almost any peptide sequence, a difficult task using other methods.

Mimetica's goal is to produce drug candidates using its unique technology and partner them for commercial development. We are seeking partnerships with pharmaceutical and biotechnology companies, particularly those with novel targets and biology capabilities, to develop drugs targeting GPCRs and other peptide receptors.

Mimetica also seeks partners with pre-clinical and regulatory experience interested in further developing our existing lead compounds.